3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Stomach Neoplasms
132
Pancreatic Neoplasms
36
Esophageal Neoplasms
19
Biliary Tract Neoplasms
18
Colorectal Neoplasms
17
Esophageal Squamous Cell Carcinoma
12
Neoplasm Metastasis
10
Cholangiocarcinoma
8
Carcinoma, Non-Small-Cell Lung
7
Gastrointestinal Neoplasms
6
Nasopharyngeal Carcinoma
5
Colonic Neoplasms
5
Adenocarcinoma
5
Neoplasms
4
Head and Neck Neoplasms
4
Advanced Pancreatic Cancer
4
Advanced Gastric Cancer
4
Recurrence
3
Rectal Neoplasms
3
Gastric Adenocarcinoma
3
Gallbladder Neoplasms
3
Advanced Solid Tumors
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
NSCLC
2
Locally Advanced Pancreatic Cancer
2
Locally Advanced Gastric Cancer
2
Gastric Cancer Peritoneal Metastases
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Interventions
Carboplatin
341
Cisplatin
239
Paclitaxel
203
Radiotherapy
195
Pemetrexed
188
Docetaxel
169
Gemcitabine
157
pembrolizumab
142
Erlotinib Hydrochloride
107
Etoposide
99
Magnetic Resonance Spectroscopy
93
Bevacizumab
91
Specimen Handling
76
Nivolumab
73
Radiosurgery
72
durvalumab
69
Vinorelbine
54
osimertinib
53
Gefitinib
49
Drug Therapy
49
atezolizumab
42
Irinotecan
42
Radiation
40
Topotecan
39
Biopsy
39
Standard of Care
38
Cyclophosphamide
38
Cetuximab
35
Blood Specimen Collection
33
Taxes
32
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lung Neoplasms
×
S 1 (combination)
×
Clear all
NCT04274270
2020-03-19
SBRTLCES
Peking University Third Hospital
Phase NA
Unknown
60 enrolled